Chad Hyett

Lupus Therapeutics Announces a New, Groundbreaking Mechanism to Fund Clinical Studies Addressing the Impact of Diet, Nutrition, and Microbiome on Lupus

|
Request for Applications: see article for details

New York, NY, November 22, 2024 — The unique IDEAL (Investigate Dietary Approaches for Lupus) Initiative will provide multidisciplinary research teams the opportunity to conduct innovative and much-needed research of diet in lupus   Lupus Therapeutics, the clinical affiliate of the Lupus Research Alliance (LRA), today announced a pioneering funding mechanism to address one of the most common questions … Lupus Therapeutics Announces a New, Groundbreaking Mechanism to Fund Clinical Studies Addressing the Impact of Diet, Nutrition, and Microbiome on Lupus

LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More

|

New York, NY, November 21, 2024 — New ACR guidelines for advancing the management of lupus nephritis (LN). Novel approaches and promising data from early- to late-stage lupus treatments in development, including CAR T cell therapies. Strategies for promoting equity in lupus clinical trials. These were among the key presentations at ACR (American College of … LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More